SK3 Group Announces Sales of New Product T-Hydroca
Post# of 36729
Posted On: 06/16/2014 10:11:19 AM
SK3 Group Announces Sales of New Product T-Hydrocan(TM) CBD 10/5
SK3 Group Announces Sales of New Product T-Hydrocan(TM) CBD 10/5
LOS ANGELES, CA--(Marketwired - Jun 16, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO) ("the Company"
is pleased to announce that the first bottles of its new medicinal cannabis product, T-Hydrocan™ CBD 10/5, is now available from Pharmajanes.com, and will soon be available from collectives that carry the Company's YAK Edibles line of medical marijuana products. T-Hydrocan™ CBD 10/5 is the third offering in Berkeley Bio's cannabinoid-based nutraceutical product line, joining Dharmamol™ and T-Hydrocan™ RMC 40.
The "CBD 10/5" indicates that each dosage unit contains 10mg. of CBD and 5 mg. of THC. The THC is in its fully activated (decarboxylated) form. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids.
T-Hydrocan™ CBD 10/5 is packaged 8 tablets per bottle. The suggested retail price is $30.00 per bottle.
T-Hydrocan™ CBD 10/5 was developed by Berkeley Bio-Organic Research Laboratories, Inc. and is available through Pharmajanes.com and select dispensaries throughout California.
"We are thrilled that we have been able to get this product to market this quickly," said David Hoye, head of Berkeley Bio-Organic Research Laboratories and director of the Company. "This product will undoubtedly help many patients improve their quality of life while realizing the benefits of CBD."
FDA Statement
The statements in this document have not been evaluated or
SK3 Group Announces Sales of New Product T-Hydrocan(TM) CBD 10/5
LOS ANGELES, CA--(Marketwired - Jun 16, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO) ("the Company"
is pleased to announce that the first bottles of its new medicinal cannabis product, T-Hydrocan™ CBD 10/5, is now available from Pharmajanes.com, and will soon be available from collectives that carry the Company's YAK Edibles line of medical marijuana products. T-Hydrocan™ CBD 10/5 is the third offering in Berkeley Bio's cannabinoid-based nutraceutical product line, joining Dharmamol™ and T-Hydrocan™ RMC 40. The "CBD 10/5" indicates that each dosage unit contains 10mg. of CBD and 5 mg. of THC. The THC is in its fully activated (decarboxylated) form. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids.
T-Hydrocan™ CBD 10/5 is packaged 8 tablets per bottle. The suggested retail price is $30.00 per bottle.
T-Hydrocan™ CBD 10/5 was developed by Berkeley Bio-Organic Research Laboratories, Inc. and is available through Pharmajanes.com and select dispensaries throughout California.
"We are thrilled that we have been able to get this product to market this quickly," said David Hoye, head of Berkeley Bio-Organic Research Laboratories and director of the Company. "This product will undoubtedly help many patients improve their quality of life while realizing the benefits of CBD."
FDA Statement
The statements in this document have not been evaluated or
(0)
(0)